Articles

Sort by
Previous Page Page 1 of 10 Next Page
  1. Research

    Economic evaluation of participatory learning and action with women’s groups facilitated by Accredited Social Health Activists to improve birth outcomes in rural eastern India

    Neonatal mortality remains unacceptably high in many low and middle-income countries, including India. A community mobilisation intervention using participatory learning and action with women’s groups facilita...

    Rajesh Kumar Sinha, Hassan Haghparast-Bidgoli, Prasanta Kishore Tripathy, Nirmala Nair, Rajkumar Gope, Shibanand Rath and Audrey Prost

    Cost Effectiveness and Resource Allocation 2017 15:2

    Published on: 21 March 2017

  2. Review

    International lessons in new methods for grading and integrating cost effectiveness evidence into clinical practice guidelines

    Economic evidence is influential in health technology assessment world-wide. Clinical Practice Guidelines (CPG) can enable economists to include economic information on health care provision. Application of ec...

    Kathryn M. Antioch, Michael F. Drummond, Louis W. Niessen and Hindrik Vondeling

    Cost Effectiveness and Resource Allocation 2017 15:1

    Published on: 10 February 2017

  3. Research

    Optimizing treatment for the prevention of pre-eclampsia/eclampsia in Nepal: is calcium supplementation during pregnancy cost-effective?

    In Nepal, pre-eclampsia/eclampsia (PE/E) causes an estimated 21% of maternal deaths annually and contributes to adverse neonatal birth outcomes. Calcium supplementation has been shown to reduce the risk of PE/...

    Isabelle Feldhaus, Amnesty E. LeFevre, Chandra Rai, Jona Bhattarai, Deirdre Russo, Barbara Rawlins, Pushpa Chaudhary and Kusum Thapa

    Cost Effectiveness and Resource Allocation 2016 14:13

    Published on: 28 December 2016

  4. Review

    Advancing aged care: a systematic review of economic evaluations of workforce structures and care processes in a residential care setting

    Long-term care for older people is provided in both residential and non-residential settings, with residential settings tending to cater for individuals with higher care needs. Evidence relating to the costs a...

    Tiffany Easton, Rachel Milte, Maria Crotty and Julie Ratcliffe

    Cost Effectiveness and Resource Allocation 2016 14:12

    Published on: 12 December 2016

  5. Research

    What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in Australia

    Zoledronic acid and denosumab were funded by the Australian government for the management of osteoporosis at an equivalent price to alendronate. The price of alendronate has declined by around 65 %, but the pr...

    Jonathan Karnon, Ainul Shakirah Shafie, Nneka Orji and Sofoora Kawsar Usman

    Cost Effectiveness and Resource Allocation 2016 14:11

    Published on: 13 October 2016

  6. Research

    Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis

    The coverage of prevention and treatment strategies for ischemic heart disease and stroke is very low in Ethiopia. In view of Ethiopia’s meager healthcare budget, it is important to identify the most cost-effe...

    Mieraf Taddesse Tolla, Ole Frithjof Norheim, Solomon Tessema Memirie, Senbeta Guteta Abdisa, Awel Ababulgu, Degu Jerene, Melanie Bertram, Kirsten Strand, Stéphane Verguet and Kjell Arne Johansson

    Cost Effectiveness and Resource Allocation 2016 14:10

    Published on: 12 August 2016

  7. Research

    Mothers’ willingness to pay for HPV vaccines in Anambra state, Nigeria: a cross sectional contingent valuation study

    Human papilloma virus (HPV) vaccination in Nigeria will require substantial financing due to high cost of HPV vaccine and inexistence of structures to support adolescent vaccination. Alternative sources are ne...

    Ifeoma Blessing Umeh, Sunday Odunke Nduka and Obinna Ikechukwu Ekwunife

    Cost Effectiveness and Resource Allocation 2016 14:8

    Published on: 6 June 2016

  8. Research

    Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema

    To conduct a cost-utility analysis of ranibizumab versus aflibercept for the treatment of patients with visual impairment due to diabetic macular edema (DME) in the Greek setting.

    Georgia Kourlaba, John Relakis, Ronan Mahon, Maria Kalogeropoulou, Georgia Pantelopoulou, Olga Kousidou and Nikos Maniadakis

    Cost Effectiveness and Resource Allocation 2016 14:7

    Published on: 14 April 2016

  9. Research

    The value of using a brain laser interstitial thermal therapy (LITT) system in patients presenting with high grade gliomas where maximal safe resection may not be feasible

    The objective of this analysis was to determine the value (incremental cost/increment benefit) of a brain LITT system versus employing current surgical options recommended by NCCN guidelines, specifically open...

    Jeffrey D. Voigt and Gene Barnett

    Cost Effectiveness and Resource Allocation 2016 14:6

    Published on: 21 March 2016

  10. Reviewer acknowledgement

    Annual acknowledgement of manuscript reviewers

    The editors of Cost Effectiveness and Resource Allocation would like to thank all our reviewers who have contributed to the journal in volume 13 (2015).

    Joan Rovira

    Cost Effectiveness and Resource Allocation 2016 14:5

    Published on: 11 March 2016

  11. Research

    The economic burden of childhood pneumococcal diseases in The Gambia

    Streptococcus pneumoniae is a common cause of child death. However, the economic burden of pneumococcal disease in low-income countries is poorly described. We aimed to estimate from a...

    Effua Usuf, Grant Mackenzie, Sana Sambou, Deborah Atherly and Chutima Suraratdecha

    Cost Effectiveness and Resource Allocation 2016 14:4

    Published on: 17 February 2016

  12. Review

    Economic evaluations of interventions to reduce neonatal morbidity and mortality: a review of the evidence in LMICs and its implications for South Africa

    Newborn mortality, comprising a third of all under-5 deaths, has hardly changed in low and middle income countries (LMICs) including South Africa over the past decade. To attain the MDG 4 target, greater empha...

    Mandy Maredza, Lumbwe Chola and Karen Hofman

    Cost Effectiveness and Resource Allocation 2016 14:2

    Published on: 26 January 2016

  13. Research

    Efficiency of private and public primary health facilities accredited by the National Health Insurance Authority in Ghana

    Despite improvements in a number of health outcome indicators partly due to the National Health Insurance Scheme (NHIS), Ghana is unlikely to attain all its health-related millennium development goals before t...

    Robert Kaba Alhassan, Edward Nketiah-Amponsah, James Akazili, Nicole Spieker, Daniel Kojo Arhinful and Tobias F Rinke de Wit

    Cost Effectiveness and Resource Allocation 2015 13:23

    Published on: 26 December 2015

  14. Research

    Cost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UK

    The cost-effectiveness of umeclidinium bromide-vilanterol (UMEC/VI) versus tiotropium monotherapy in the UK was assessed using a UMEC/VI treatment-specific economic model based on a chronic obstructive pulmona...

    Yogesh Suresh Punekar, Graeme Roberts, Afisi Ismaila and Martin O’Leary

    Cost Effectiveness and Resource Allocation 2015 13:22

    Published on: 12 December 2015

  15. Research

    Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey

    All international guidelines suggested that Tenofovir and Entecavir are the primary drugs at the first line therapy for the treatment of chronic hepatitis B (CHB). However, in Turkey these medications reimburs...

    Guvenc Kockaya, Akin Kose, Fatma Betul Yenilmez, Oktay Ozdemir and Ece Kucuksayrac

    Cost Effectiveness and Resource Allocation 2015 13:21

    Published on: 10 December 2015

  16. Research

    Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methods

    In the Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST elevation myocardial infarction (FAMOUS) clinical trial, FFR was shown to significantly reduce coro...

    Julian Nam, Andrew Briggs, Jamie Layland, Keith G. Oldroyd, Nick Curzen, Arvind Sood, Kanarath Balachandran, Raj Das, Shahid Junejo, Hany Eteiba, Mark C. Petrie, Mitchell Lindsay, Stuart Watkins, Simon Corbett, Brian O’Rourke, Anna O’Donnell…

    Cost Effectiveness and Resource Allocation 2015 13:19

    Published on: 14 November 2015

  17. Research

    Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-α antagonists in management of ankylosing spondylitis: a dynamic population modelling study

    Sequential treatment of ankylosing spondylitis (AS) that includes tumour necrosis factor-α antagonists (anti-TNF agents) has been applied in most of the Western countries. Existing cost-effectiveness (CE) mode...

    An Tran-Duy, Annelies Boonen, Mart A. F. J. van de Laar and Johan L. Severens

    Cost Effectiveness and Resource Allocation 2015 13:18

    Published on: 7 October 2015

  18. Research

    New all oral therapy for chronic hepatitis C virus (HCV): a novel long-term cost comparison

    In the US, the prevalence of hepatitis C virus (HCV) has surpassed the prevalence of human immunodeficiency virus (HIV), with about 3.3 million people chronically infected with the disease. Given the aging of ...

    Jennifer M. Poonsapaya, Michael Einodshofer, Heather S. Kirkham, Pheophilus Glover and Janeen DuChane

    Cost Effectiveness and Resource Allocation 2015 13:17

    Published on: 6 October 2015

  19. Research

    Matching comprehensive health insurance reimbursements to their real costs: the case of antenatal care visits in a region of Peru

    Prepaid contributory systems are increasingly being recognized as key mechanisms in achieving universal health coverage in low and middle-income countries. Peru created the Seguro Integral de Salud (SIS) to in...

    Daniel Cobos Muñoz, Kristian Schultz Hansen, Fern Terris-Prestholt, Fiona Cianci, José Enrique Pérez-Lu, Aldo Lama and Patricia J. García

    Cost Effectiveness and Resource Allocation 2015 13:16

    Published on: 19 September 2015

  20. Research

    Is chest X-ray screening for lung cancer in smokers cost-effective? Evidence from a population-based study in Italy

    After implementation of the PREDICA annual chest X-ray (CXR) screening program in smokers in the general practice setting of Varese-Italy a significant reduction in lung cancer-specific mortality (18 %) was ob...

    Paolo Pertile, Albino Poli, Lorenzo Dominioni, Nicola Rotolo, Elisa Nardecchia, Massimo Castiglioni, Massimo Paolucci, William Mantovani and Andrea Imperatori

    Cost Effectiveness and Resource Allocation 2015 13:15

    Published on: 12 September 2015

Previous Page Page 1 of 10 Next Page